Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Working Capital to Net Assets Ratio
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Working Capital to Net Assets ratio of -4.5% as of March 2026. Working capital of CN¥-143.73 Million (current assets of CN¥2.53 Billion minus current liabilities of CN¥2.67 Billion) is measured against net assets of CN¥3.20 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Guizhou Bailing Group Pharmaceutical Co to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guizhou Bailing Group Pharmaceutical Co Ltd Working Capital to Net Assets (2007–2025)
This chart shows how Guizhou Bailing Group Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at -4.5%, reflecting working capital of CN¥-143.73 Million against net assets of CN¥3.20 Billion CNY. Check Guizhou Bailing Group Pharmaceutical Co (002424) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Guizhou Bailing Group Pharmaceutical Co market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -2.4% | CN¥-75.98 Million | CN¥3.17 Billion | CN¥2.72 Billion | CN¥2.80 Billion | ▲ +2.5 pp |
| 2024 | -4.9% | CN¥-156.19 Million | CN¥3.20 Billion | CN¥3.64 Billion | CN¥3.80 Billion | ▼ -19.0 pp |
| 2023 | 14.1% | CN¥497.49 Million | CN¥3.53 Billion | CN¥4.01 Billion | CN¥3.52 Billion | ▼ -12.2 pp |
| 2022 | 26.3% | CN¥1.05 Billion | CN¥4.00 Billion | CN¥3.82 Billion | CN¥2.77 Billion | ▼ -3.4 pp |
| 2021 | 29.7% | CN¥1.18 Billion | CN¥3.96 Billion | CN¥3.53 Billion | CN¥2.35 Billion | ▼ -14.5 pp |
| 2020 | 44.2% | CN¥1.73 Billion | CN¥3.92 Billion | CN¥4.60 Billion | CN¥2.86 Billion | ▼ -2.1 pp |
| 2019 | 46.3% | CN¥1.91 Billion | CN¥4.14 Billion | CN¥4.58 Billion | CN¥2.67 Billion | ▼ -4.0 pp |
| 2018 | 50.3% | CN¥1.97 Billion | CN¥3.92 Billion | CN¥4.00 Billion | CN¥2.02 Billion | ▼ -16.8 pp |
| 2017 | 67.1% | CN¥2.32 Billion | CN¥3.47 Billion | CN¥3.65 Billion | CN¥1.32 Billion | ▼ -0.8 pp |
| 2016 | 67.9% | CN¥2.08 Billion | CN¥3.07 Billion | CN¥3.21 Billion | CN¥1.13 Billion | ▲ +1.3 pp |
| 2015 | 66.5% | CN¥1.78 Billion | CN¥2.68 Billion | CN¥2.91 Billion | CN¥1.12 Billion | ▲ +4.4 pp |
| 2014 | 62.2% | CN¥1.46 Billion | CN¥2.35 Billion | CN¥2.64 Billion | CN¥1.18 Billion | ▲ +2.7 pp |
| 2013 | 59.4% | CN¥1.26 Billion | CN¥2.13 Billion | CN¥2.57 Billion | CN¥1.31 Billion | ▼ -3.7 pp |
| 2012 | 63.1% | CN¥1.29 Billion | CN¥2.04 Billion | CN¥2.38 Billion | CN¥1.09 Billion | ▼ -20.5 pp |
| 2011 | 83.7% | CN¥1.62 Billion | CN¥1.94 Billion | CN¥2.45 Billion | CN¥831.53 Million | ▼ -12.6 pp |
| 2010 | 96.3% | CN¥1.78 Billion | CN¥1.85 Billion | CN¥2.60 Billion | CN¥820.48 Million | ▲ +30.0 pp |
| 2009 | 66.3% | CN¥248.10 Million | CN¥374.42 Million | CN¥692.61 Million | CN¥444.51 Million | ▲ +10.4 pp |
| 2008 | 55.9% | CN¥146.84 Million | CN¥262.75 Million | CN¥465.15 Million | CN¥318.31 Million | ▲ +16.5 pp |
| 2007 | 39.4% | CN¥71.90 Million | CN¥182.68 Million | CN¥385.36 Million | CN¥313.46 Million | — |